Johnson & Johnson (JNJ) Shareholder Intersect Capital Has Raised Holding by $367,908 as Stock Declined; Davis Selected Advisers Increases Stake in Quest Diagnostics (DGX)

Johnson & Johnson (NYSE:JNJ) Logo

Davis Selected Advisers increased its stake in Quest Diagnostics Inc. (DGX) by 502.38% based on its latest 2018Q4 regulatory filing with the SEC. Davis Selected Advisers bought 665,853 shares as the company’s stock declined 11.57% while stock markets rallied. The institutional investor held 798,392 shares of the medical specialities company at the end of 2018Q4, valued at $66.29M, up from 132,539 at the end of the previous reported quarter. Davis Selected Advisers who had been investing in Quest Diagnostics Inc. for a number of months, seems to be bullish on the $11.46 billion market cap company. The stock decreased 4.41% or $3.93 during the last trading session, reaching $85.16. About 883,629 shares traded. Quest Diagnostics Incorporated (NYSE:DGX) has declined 14.63% since April 17, 2018 and is downtrending. It has underperformed by 19.00% the S&P500. Some Historical DGX News: 14/03/2018 – Genomic Vision Extends Its Collaboration with Quest Diagnostics in Spinal Muscular Atrophy (SMA); 19/04/2018 – Quest Diagnostics Profit Rises, Backs 2018 Outlook; 19/04/2018 – QUEST DIAGNOSTICS 1Q ADJ EPS $1.52, EST. $1.50; 19/04/2018 – QUEST DIAGNOSTICS INC – OUTLOOK FOR FULL YEAR 2018 REMAINS UNCHANGED; 17/05/2018 – Quest Diagnostics adds Helen Torley to Board of Directors; 14/03/2018 – QUEST DIAGNOSTICS INC DGX.N : MORGAN STANLEY RAISES TARGET PRICE TO $103 FROM $95; 16/05/2018 – Quest Diagnostics Presenting at Conference Jun 13; 25/05/2018 – Quest Diagnostics Closes Above 50-Day Moving Average; 08/05/2018 – Quest Diagnostics at Deutsche Bank Conference Tomorrow; 19/04/2018 – QUEST DIAGNOSTICS INC QTRLY REPORTED DILUTED EPS OF $1.27

Intersect Capital Llc increased its stake in Johnson & Johnson (JNJ) by 7.96% based on its latest 2018Q4 regulatory filing with the SEC. Intersect Capital Llc bought 2,852 shares as the company’s stock declined 5.44% while stock markets rallied. The institutional investor held 38,685 shares of the major pharmaceuticals company at the end of 2018Q4, valued at $4.99M, up from 35,833 at the end of the previous reported quarter. Intersect Capital Llc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $370.13 billion market cap company. The stock increased 0.71% or $0.98 during the last trading session, reaching $139. About 6.43 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 8.80% since April 17, 2018 and is uptrending. It has outperformed by 4.43% the S&P500. Some Historical JNJ News: 16/03/2018 – CBS Sports: NFL Free Agency Rumors: Tyrann Mathieu agrees to join J.J. Watt on Texans defense; 17/04/2018 – J&J SEES PRETAX RESTRUCTURING CHARGES $1.9B-$2.3B; 11/04/2018 – J&J: One-of-a-Kind Contact Lens Corrects Vision and Adapts to Changing Light Conditions; 17/04/2018 – J&J – FIRST-QUARTER NET EARNINGS ALSO INCLUDED CHARGE FOR AFTER-TAX SPECIAL ITEMS OF APPROXIMATELY $0.3 BLN; 16/03/2018 – J&J – ACCEPTANCE PERIOD FOR OFFER WILL END ON JUNE 15, 2018; 03/05/2018 – Johnson & Johnson to Participate in the 2018 UBS Global Health Care Conference; 24/04/2018 – CN RAIL CEO JJ RUEST SPEAKS IN INTERVIEW IN TORONTO; 02/05/2018 – Johnson & Johnson Comes in at #1 on the 2018 DiversityInc Top 50 Companies List; 21/05/2018 – J&J: EMBOTRAP II STENT RETRIEVER FOR ISCHEMIC STROKE; 16/03/2018 – J&J SAYS DEAL CONTEMPLATED IN GUIDANCE PROVIDED JAN. 23

Investors sentiment decreased to 0.86 in Q4 2018. Its down 0.19, from 1.05 in 2018Q3. It worsened, as 51 investors sold JNJ shares while 851 reduced holdings. 145 funds opened positions while 631 raised stakes. 1.79 billion shares or 5.17% more from 1.70 billion shares in 2018Q3 were reported. Amg Natl Tru Fincl Bank has invested 0.03% in Johnson & Johnson (NYSE:JNJ). Stack Management Inc owns 86,574 shares. Virginia-based Culbertson A N Communications Inc has invested 3.01% in Johnson & Johnson (NYSE:JNJ). Marietta Ptnrs Ltd holds 5,162 shares or 0.25% of its portfolio. Marco Limited Liability invested 0.84% in Johnson & Johnson (NYSE:JNJ). Boyar Asset Mngmt accumulated 2.22% or 20,849 shares. Signature Mngmt stated it has 11,876 shares. Mackay Shields Llc has invested 0.82% in Johnson & Johnson (NYSE:JNJ). Wilkins Invest Counsel accumulated 76,879 shares or 3.29% of the stock. Moreover, Parsons Capital Mgmt Inc Ri has 2.07% invested in Johnson & Johnson (NYSE:JNJ) for 130,175 shares. Stewart & Patten Communication Ltd Liability Corporation reported 199,941 shares. Vantage Invest Prns Ltd Liability Corporation reported 69,088 shares. Hikari Limited has invested 4% in Johnson & Johnson (NYSE:JNJ). Moreover, Sequoia Fincl Llc has 0.26% invested in Johnson & Johnson (NYSE:JNJ) for 17,710 shares. Regions invested in 0.77% or 477,998 shares.

Since November 7, 2018, it had 3 buys, and 6 selling transactions for $74.45 million activity. Shares for $1.23M were sold by Kapusta Ronald A on Thursday, November 8. Shares for $24.41M were sold by Fasolo Peter on Monday, December 3. 1,000 shares valued at $133,910 were bought by PEREZ WILLIAM D on Friday, December 14. Duato Joaquin also sold $5.77 million worth of Johnson & Johnson (NYSE:JNJ) shares. PRINCE CHARLES had bought 2,000 shares worth $268,731. Shares for $38.60 million were sold by Gorsky Alex on Friday, November 16.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “J&J: No settlement program for Baby Powder cases – Seeking Alpha” on March 28, 2019, also Seekingalpha.com with their article: “J&J baby shampoo samples fail Indian quality test – Seeking Alpha” published on April 01, 2019, Seekingalpha.com published: “Legal battle against opioid crisis heats up – Seeking Alpha” on March 26, 2019. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Investorplace.com and their article: “Why The Rally In Johnson & Johnson Stock May Top Out At $150 – Investorplace.com” published on April 17, 2019 as well as Streetinsider.com‘s news article titled: “Janssen (JNJ) Submits BLA for DARZALEX to Treat Multiple Myeloma – StreetInsider.com” with publication date: March 26, 2019.

Davis Selected Advisers, which manages about $48.17B and $17.90 billion US Long portfolio, decreased its stake in Cabot Oil & Gas Corp. (NYSE:COG) by 48,674 shares to 579,300 shares, valued at $13.09M in 2018Q4, according to the filing. It also reduced its holding in Sl Green Realty Corp. (NYSE:SLG) by 26,813 shares in the quarter, leaving it with 72,350 shares, and cut its stake in Fang Holdings Ltd. Adr.

Quest Diagnostics Incorporated (NYSE:DGX) Institutional Positions Chart